Pharmaceuticals & Biotechnology | Pharma & Biotech Resources
Summary: Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community Through Pharma IQ, you will be able to access pharmaceutical information resources such as
- Visit Website
- RSS
- Artist: Unknown
Podcasts:
In today's age of electronic communication, the ability to properly protect, monitor and disseminate information being transferred becomes more difficult. In this podcast, Joseph Mariano, a Records System Analyst in the Pharmaceutical Industry, discusses new innovative processes and
As legislation gets more sophisticated, organisations like Quosa, part of Elsevier, continue to look for new ways to support those working in pharmacovigilance, by speeding up automation and increasing capacity through literature management software
As legislation gets more sophisticated, organisations like Quosa, part of Elsevier, continue to look for new ways to support those working in pharmacovigilance, by speeding up automation and increasing capacity through literature management software
Expected for a long time, USP has published a new draft to revise the General Chapters 41 “Balances” and 1251 “Weighing on an Analytical Balance” in the Pharmacopeial Forum PF 38(5) on September 4, 2012. One consequence of General Chapter 41 is the so-called
Pharmacovigilance is something that has no borders and in July this year, some key regulations were passed which will have a profound effect conceptually and technically on those who are working with pharma products which are commercialised in the EU. However,
Implementing effective pathogen safety strategies is essential for preventing contamination and ensuring the safety of your biologics. Raw materials can bring a pathogen or virus into your manufacturing plant and raw material control is of paramount importance to
Implementing effective pathogen safety strategies is essential for preventing contamination and ensuring the safety of your biologics. Raw materials can bring a pathogen or virus into your manufacturing plant and raw material control is of paramount importance to
Even a slight change to a regulation can have a huge effect throughout an organization. Given the recent overhaul of the EMA drug safety requirements, the ‘ripple effect’ is more like a tidal wave. In this podcast, Amber Scorah of Pharma IQ, gets some best practices for
There are many methods of signal detection, however, most of the methods currently in use are outdated for the volume of data. Signal detection systems are regulatorily mandated, but no company has the time or manpower to troll through mounds of data without effective automation. In this
Even a slight change to a regulation can have a huge effect throughout an organization. Given the recent overhaul of the EMA drug safety requirements, the ‘ripple effect’ is more like a tidal wave. In this podcast, Amber Scorah of Pharma IQ, gets some best practices for
There are many methods of signal detection, however, most of the methods currently in use are outdated for the volume of data. Signal detection systems are regulatorily mandated, but no company has the time or manpower to troll through mounds of data without effective automation. In this
One of the main challenges when working with Amorphous materials is being able to predict and characterise properties which are common to crystalline products. Yaroslav Khimyak, Professor in NMR at the University of East Anglia in the UK explains to Pharma IQ. Listen to his
Most big pharma are now setting up operations in Asia, with China predicted to be the biggest market in pharmaceuticals by 2025. Mark McHale, Chief Scientific Officer at Aslan Pharmaceuticals discusses the set up of the pharma organisation in Singapore over two years ago,
Array Biopharma was one of the first pharmaceutical organisations to implement an ELN 11 years ago. Cat Andersen and the team at Array have been instrumental to ensuring its sucess. She spoke to Pharma IQ about the secret behind a successful integration with an existing informatics
It’s no secret that pharma and bio are struggling to fill their pipelines . Dan Sfera from The Clinical Trials Guru, joins Andrea Charles from Pharma IQ to discuss specific challenges that arise in conducting Phase 1 studies and the additional skills that are
